A recent study reveals a complex relationship between SSRI antidepressant use during pregnancy and various health outcomes for both mothers and newborns. But are the benefits worth the potential risks?
An international research team has uncovered a link between taking SSRIs during pregnancy and an increased likelihood of gestational diabetes and newborn adaptation issues. Interestingly, this finding persists even when considering maternal depression, a condition often treated with SSRIs. However, the study also suggests that SSRI use might reduce the risks of preterm birth and low birth weight.
The population-based study compared women who took SSRIs during pregnancy with those who had depression but didn't use medication. The results? A higher risk of gestational diabetes for SSRI users, but a lower risk of caesarean section, very preterm birth, and low birth weight.
And here's where it gets controversial: while SSRI exposure in newborns was linked to lower Apgar scores, breathing difficulties, and a need for neonatal care, there was no increased risk of major congenital malformations.
The study further compared women who took SSRIs during pregnancy with those who discontinued SSRIs before pregnancy. The former group had a lower risk of late preterm birth and low birth weight, but the risks of newborn adaptation problems remained higher.
Lead researcher Docent Heli Malm highlights the importance of personalized treatment decisions during pregnancy. While SSRIs might protect against preterm birth risks associated with depression, close monitoring of both the pregnancy and newborn health is essential.
Malm also emphasizes the need for further research to understand the connection between SSRI use and gestational diabetes, as the underlying cause-and-effect relationship remains unclear.
This extensive study, involving over 1.27 million children born in Finland, used various control groups, including sibling comparisons, to account for genetic and environmental factors. The aim was to distinguish between the effects of SSRI medication and maternal depression on prenatal risks.
So, what does this mean for expectant mothers? The study underscores the complexity of balancing the benefits and risks of SSRI use during pregnancy. While it may reduce certain pregnancy complications, it also introduces potential challenges for newborns. As always, medical decisions should be made in consultation with healthcare professionals, considering individual circumstances.
